DBV Technologies S.A.
NASDAQ:DBVT · NASDAQ Global Select
-$0.16 today
Vol 0.32M · Avg 0.24M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+81.43%
Period High
$24.54
Period Low
$8.51
Latest
$15.53
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
LB Pharmaceuticals Inc Common Stock
NASDAQ:LBRX
$851.55M
Alto Neuroscience, Inc.
NYSE:ANRO
$778.73M
Annexon, Inc.
NASDAQ:ANNX
$585.91M
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO
$387.62M
Amarin Corporation plc
NASDAQ:AMRN
$334.13M
Cellectis S.A.
NASDAQ:CLLS
$311.28M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$299.99M
Altimmune, Inc.
NASDAQ:ALT
$239.35M
Korro Bio, Inc.
NASDAQ:KRRO
$125.51M
enGene Holdings Inc.
NASDAQ:ENGN
$88.06M
What is the latest DBVT filing?
The latest filing shown is 8-K dated Jun 5, 2026.
How many recent filings does DBVT have?
Intrinsic Alpha currently shows 20 recent filings for DBVT.
Explore More
Continue the stock analysis
Jump to another research area for this company.